Press Releases

Date	Title and Summary	Additional Formats
Toggle SummarySeptember 15, 2003	Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research -- Study Expands Aastrom's Tumor Antigen Primed Vaccine Approach to Ovarian Cancer --	View HTML Aastrom Biosciences Receives NIH Grant for Dendritic Cell Vaccine Research 16.1 KB
Toggle SummarySeptember 2, 2003	Aastrom Biosciences Receives FDA Approval to Initiate Multi-Center Clinical Trial for Bone Graft Product -- IND Approval Key Milestone for Aastrom's Stem Cell Product Program for Tissue Generation --	View HTML Aastrom Biosciences Receives FDA Approval to Initiate Multi-Center Clinical Trial for Bone Graft Product 17 KB
Toggle SummaryAugust 26, 2003	Aastrom Biosciences, Inc. Reports Fourth Quarter Financial Results Aastrom Biosciences, Inc. Reports Fourth Quarter Financial Results Ann Arbor, Michigan, August 26, 2003 -- Aastrom Biosciences, Inc. (NasdaqSC: ASTM) announced today financial results for the fourth quarter and fiscal year ended June 30, 2003. The Company also reported significant achievements	View HTML Aastrom Biosciences, Inc. Reports Fourth Quarter Financial Results 25 KB
Toggle SummaryAugust 21, 2003	Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell Therapy Product -- Expands Aastrom's Cell Production Products Business --	View HTML Aastrom Biosciences Completes CE Mark Requirements for Third Dendritic Cell Therapy Product 16.7 KB

Investor Relations